Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cell therapy in twin children with cerebral palsy
ChiCTR-ONC-12003124Phase 4Completed
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- Oct 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of human umbilical cord mesenchymal stem cells in cerebral palsy (CP), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoints: Gross Motor Function Measure and Fine Motor Function Measure. Started Oct 2012; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on ChiCTR-ONC-12003124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12003124.